Article Text

Download PDFPDF
Selected highlights from other veterinary journals

Statistics from

Clinical evaluation of combination drug therapy in dogs with epilepsy

J. Neßler, C. Rundfeldt, W. Löscher, D. Kostic, T. Keefe, A. Tipold

IDIOPATHIC epilepsy is diagnosed in dogs that experience chronic spontaneous seizure activity but do not show neurological abnormalities in the period between seizures.

Imepitoin, an anti-epileptic drug used for canine idiopathic epilepsy treatment, has a high efficacy for the treatment of generalised seizures and an improved safety profile compared to phenobarbital. However, imepitoin currently has no specific add-on therapy label for combination treatment with other anti-epileptic drugs. This study aimed to determine the safety and efficacy of combination treatment of imepitoin with phenobarbital in dogs that showed drug resistance to previous treatment.

In total 34 dogs were enrolled in the study: 16 in cohort A, 11 in cohort B and seven in cohort C. In cohort A, dogs not responding to phenobarbital (with or without add-on treatment of potassium bromide or levetiracetam) were treated add-on with imepitoin, starting at 10 mg/kg twice daily and increasing up to 30 mg/kg twice daily. In cohort B, the only difference to cohort A was that the starting dose of imepitoin was reduced to 5 mg/kg twice daily. In cohort C, animals not responding to imepitoin at more than 20 mg/kg twice daily were treated …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.